An Open-label Single Arm Phase 2 Proof of Concept Study to Assess the Efficacy and Safety of ASCT01 in Patients With Critical Limb Ischemia
Phase of Trial: Phase II
Latest Information Update: 26 Feb 2019
Price : $35 *
At a glance
- Drugs ASCT 01 (Primary) ; ASCT 01 (Primary)
- Indications Peripheral ischaemia
- Focus Proof of concept; Therapeutic Use
- Sponsors Lifecells LLC
- 20 Apr 2016 Status changed from recruiting to completed.
- 21 Jul 2014 Placebo group removed, no of tt. arms changed from 2 to 1, age range changed, study design and official title got changed.
- 01 Apr 2014 New trial record